Terms: = Pancreatic cancer AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin AND Treatment
17 results:
1. Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice.
Zhang J; Lin XT; Yu HQ; Fang L; Wu D; Luo YD; Zhang YJ; Xie CM
Exp Mol Med; 2023 Oct; 55(10):2162-2176. PubMed ID: 37653031
[TBL] [Abstract] [Full Text] [Related]
2. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
Navale P; Chatterjee D; Itani M; Trikalinos NA
Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
[TBL] [Abstract] [Full Text] [Related]
3. A systems biology approach to define mechanisms, phenotypes, and drivers in PanNETs with a personalized perspective.
Werle SD; Ikonomi N; Lausser L; Kestler AMTU; Weidner FM; Schwab JD; Maier J; Buchholz M; Gress TM; Kestler AMR; Kestler HA
NPJ Syst Biol Appl; 2023 Jun; 9(1):22. PubMed ID: 37270586
[TBL] [Abstract] [Full Text] [Related]
4. Interim Analysis of a Prospective Validation of 2 Blood-Based Genomic Assessments (PPQ and NETest) to Determine the Clinical Efficacy of
Bodei L; Raj N; Do RK; Mauguen A; Krebs S; Reidy-Lagunes D; Schöder H
J Nucl Med; 2023 Apr; 64(4):567-573. PubMed ID: 36396457
[TBL] [Abstract] [Full Text] [Related]
5. Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer.
Lu SY; Hua J; Liu J; Wei MY; Liang C; Meng QC; Zhang B; Yu XJ; Wang W; Xu J
BMC Med Genomics; 2022 Oct; 15(1):218. PubMed ID: 36261830
[TBL] [Abstract] [Full Text] [Related]
6. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.
Ruggeri RM; Benevento E; De Cicco F; Fazzalari B; Guadagno E; Hasballa I; Tarsitano MG; Isidori AM; Colao A; Faggiano A;
J Endocrinol Invest; 2023 Feb; 46(2):213-234. PubMed ID: 36038743
[TBL] [Abstract] [Full Text] [Related]
7. Mechanistic Target of Rapamycin (mTOR) Inhibitors.
Wang D; Eisen HJ
Handb Exp Pharmacol; 2022; 272():53-72. PubMed ID: 35091825
[TBL] [Abstract] [Full Text] [Related]
8. Establishment of Slice Cultures as a Tool to Study the cancer Immune Microenvironment.
Jiang X; Seo YD; Sullivan KM; Pillarisetty VG
Methods Mol Biol; 2019; 1884():283-295. PubMed ID: 30465211
[TBL] [Abstract] [Full Text] [Related]
9. Everolimus.
Hasskarl J
Recent Results Cancer Res; 2018; 211():101-123. PubMed ID: 30069763
[TBL] [Abstract] [Full Text] [Related]
10. Death-associated protein kinase 1 promotes growth of p53-mutant cancers.
Zhao J; Zhao D; Poage GM; Mazumdar A; Zhang Y; Hill JL; Hartman ZC; Savage MI; Mills GB; Brown PH
J Clin Invest; 2015 Jul; 125(7):2707-20. PubMed ID: 26075823
[TBL] [Abstract] [Full Text] [Related]
11. Neurogenin 3-directed cre deletion of tsc1 gene causes pancreatic acinar carcinoma.
Ding L; Han L; Li Y; Zhao J; He P; Zhang W
Neoplasia; 2014 Nov; 16(11):909-17. PubMed ID: 25425965
[TBL] [Abstract] [Full Text] [Related]
12. Everolimus.
Hasskarl J
Recent Results Cancer Res; 2014; 201():373-92. PubMed ID: 24756805
[TBL] [Abstract] [Full Text] [Related]
13. pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (tsc2) mutation.
Bombardieri R; Moavero R; Roberto D; Cerminara C; Curatolo P
Endocr Pract; 2013; 19(5):e124-8. PubMed ID: 23757617
[TBL] [Abstract] [Full Text] [Related]
14. pancreatic neuroendocrine tumors: role of novel agents. Highlights from the "2011 ASCO Gastrointestinal cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Strimpakos AS; Syrigos KN; Saif MW
JOP; 2011 Mar; 12(2):117-9. PubMed ID: 21386634
[TBL] [Abstract] [Full Text] [Related]
15. New insights into the role of the tuberous sclerosis genes in leukemia.
Rosner M; Fuchs C; Siegel N; Valli A; Hengstschläger M
Leuk Res; 2009 Jul; 33(7):883-5. PubMed ID: 19286253
[TBL] [Abstract] [Full Text] [Related]
16. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Starker LF; Carling T
Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
[TBL] [Abstract] [Full Text] [Related]
17. Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.
Jensen RT; Berna MJ; Bingham DB; Norton JA
Cancer; 2008 Oct; 113(7 Suppl):1807-43. PubMed ID: 18798544
[TBL] [Abstract] [Full Text] [Related]
